Table 1.
Visit 1 | Visit 2 | Visit 3 | Visit 4 | Visit 5 | |
---|---|---|---|---|---|
1987–89 | 1990–92 | 1993–95 | 1996–98 | 2011–13 | |
N | 14,688 | 13,363 | 12,011 | 10,867 | 6,131 |
Female, % | 54.5 | 54.6 | 54.9 | 55.0 | 58.0 |
Black, % | 27.9 | 25.7 | 24.0 | 23.5 | 24.2 |
Mean Age, years (range) | 54 (44–66) | 57 (46–70) | 60 (49–73) | 63 (52–75) | 76 (66–90) |
Education, % | |||||
Less than high school | 24.2 | 22.2 | 20.7 | 19.7 | 15.3 |
High school/equivalent | 40.6 | 41.3 | 41.6 | 41.9 | 41.5 |
College or above | 35.2 | 36.5 | 37.7 | 38.4 | 43.2 |
Anthropometrics | X | X | X | X | X |
Medical History | X | X | X | X | X |
Dietary Intake | X | X | |||
Medication Survey | X | X | X | X | X |
Physical Activity | X | X | |||
Physical Ability | X | ||||
Reproductive History | X | X | X | X | |
Cognitive Function | X | X | X | ||
Biomarkers (fasted) | |||||
Glucose | X | X | X | X | X |
Insulin | X | X | X | X | |
Glycated hemoglobin | X | X | |||
CBC | X | X | X | ||
Blood clotting factors | X | ||||
Total cholesterol | X | X | X | X | X |
HDL cholesterol | X | X | X | X | X |
LDL cholesterol | X | X | X | X | X |
Triglycerides | X | X | X | X | X |
HS C-reactive protein | X | ||||
Cystatin C | X | ||||
Vitamin D | X | ||||
Troponin | X | ||||
Biospecimens | |||||
Serum, plasma | X | X | X | X | X |
Whole blood | X | X | |||
Buffy coat | X | X | X | X | X |
Extracted DNA | X | X | |||
Urine | X | X |
Of the 15,641 ARIC participants considered eligible for the ARIC Cancer cohort because they consented to cancer research and were linkable to registry data, we excluded 906 participants with a prevalent cancer at baseline and 47 participants who reported a race/ethnicity other than Black or White from this table.